Risk of customer and patient information leakage
First written in FY2017. 14 of 16 entries say "Restated". Latest entry: FY2027-H1.
The whole theme swung hardest in 2026: 18 of 81 companies on the "Worse" side.
- FY2027-H1RestatedAnnual report
「No new business or other risks arose during the six months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there have been no material changes in the risk of customer and patient information leakage. - FY2025-H1RestatedAnnual report
「No new business or other risks arose during the interim consolidated accounting period. In addition, there were no significant changes to the business and other risks described in the previous fiscal year's Annual Securities Report.」
It was stated that there have been no material changes in the risk of customer and patient information leakage. - FY2024-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It stated that there have been no material changes in the risk of customer and patient information leakage. - FY2023RestatedAnnual report
「The Group holds customer information generated through the operation of its loyalty card system, patient information generated through its prescription dispensing operations, employee information and other data, and manages it by computer.」
The company continues to manage customer, patient and employee information and address the risks to credibility and business performance in the event of a leak through audits, training and committee oversight. - FY2023-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It stated that there have been no material changes in the risk of customer and patient information leakage. - FY2022RestatedAnnual report
「The company holds customer information generated through the operation of its loyalty card system, patient information generated through its prescription dispensing operations, employee information and other data, and manages it by computer.」
The risks associated with computer management of customer, patient and employee information and the impact on credibility and business performance in the event of a leak remain unchanged. - FY2022-Q2RestatedAnnual report
「During the second quarter consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
It was stated that there have been no material changes in the risk of customer and patient information leakage. - FY2022-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there have been no material changes in the risk of customer and patient information leakage. - FY2021MitigatedAnnual report
「In accordance with the Act on the Protection of Personal Information, the Group has established an information management framework, conducts monitoring through its Internal Audit Office, provides regular training and addresses risk mitigation by confirming the status of controls through its Compliance and Risk Management Committee.」
The company described measures addressing the risk of information leakage through monitoring by the Internal Audit Office, regular training and status reviews by the committee. - FY2020-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It stated that there have been no material changes in the risk of customer and patient information leakage. - FY2019RestatedAnnual report
「The company holds customer information generated through the operation of its loyalty card system and patient information generated through its prescription dispensing operations, and manages this information by computer. Although it takes every possible precaution in managing this information in accordance with the Act on the Protection of Personal Information, if information were to leak, the Group could be affected in terms of business performance, including through damage to its social credibility.」
The risks associated with computer management of customer and patient information and the impact on credibility and business performance in the event of a leak remain unchanged. - FY2019-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It stated that there have been no material changes in the risk of customer and patient information leakage. - FY2019-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It stated that there have been no material changes in the risk of customer and patient information leakage. - FY2018RestatedAnnual report
「The company holds customer information generated through the operation of its loyalty card system and patient information generated through its prescription dispensing operations, and manages this information by computer. Although it takes every possible precaution in managing this information in accordance with the Act on the Protection of Personal Information, if information were to leak, the Group could be affected in terms of business performance, including through damage to its social credibility.」
The risks associated with computer management of customer and patient information and the impact on credibility and business performance in the event of a leak remain unchanged. - FY2018-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It stated that there have been no material changes in the risk of customer and patient information leakage. - FY2017First statedAnnual report
「If information were to leak, the Group could be affected in terms of business performance, including through damage to its social credibility.」
The company disclosed the risk of leakage associated with holding and computer-managing customer information from its loyalty card system and patient information from its prescription dispensing operations.